Penn Capital Management Company, LLC

Position in KNSA — Kiniksa Pharmaceuticals International, plc

CIK 1158202 PHILADELPHIA, PA

Back to KNSA Full portfolio

Position in KNSA

as of Jun 30, 2026 · filed Jul 30, 2026 Compact

Position Value

$23,540,890

+$8,999,928 QoQ

Shares Held

368,114

+21.9% QoQ

Ownership

0.236%

of shares outstanding

% of Portfolio

1.50%

of 13F equity value

Holder Rank

#36

of 266 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in KNSA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Penn Capital Management Company, LLC holds $80,501,316 across 6 Drug Manufacturers - Specialty & Generic names. KNSA ranks #1 (29.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	KNSA	Kiniksa Pharmaceuticals International, plc This page	368,114	$23,540,890
2	AMRX	Amneal Pharmaceuticals, Inc.	1,181,176	$20,446,156
3	ANIP	Ani Pharmaceuticals Inc	207,362	$17,165,426
4	LNTH	Lantheus Holdings, Inc.	153,877	$17,071,114
5	NBIX	Neurocrine Biosciences Inc	10,600	$1,786,524
6	XERS	Xeris Biopharma Holdings, Inc.	62,021	$491,206

All Filings in KNSA

Export CSV

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$23,540,890	368,114	+21.9%	Shares	Sole	2026-07-30
2026-03-31	$14,540,962	301,993	—	Shares	Sole	2026-05-07
No filing history on record for this holder in this stock.